Study Activation

NCI-Designated Cancer Center (2017 – Present)
Partnered with an NCI-Designated Cancer Center in New York City to pilot em-PACT for managing the activation of all interventional trials. The use of em-PACT has resulted in a ~26% reduction in study activation timelines and a ~20% increase in staff and investigator satisfaction with the activation process. More than 100 studies have been activated using em-PACT to date and em-PACT continues to be used as the primary system for activating trials at the Cancer Center. Signed a 2-year agreement in 2019 to continue using the em-PACT solution as their primary system for activating trials.

For more information visit us at em-PACT’s home page

Joint Publication at the Association of American Cancer Institutes (AACI) Clinical Research Initiative (CRI)
2018: “Improving Study Activation Timelines Using a Workflow Management Approach”

AACI CRI 2018 Abstract

2017: “Improving Study Activation Timelines: Establishing Flow”

AACI CRI 2017 Abstract

AACI CRI 2017 Poster

Government Agency (2011)
Documented the requirements for an electronic protocol lifecycle tracking tool (PLT) to serve as the foundation for developing a tool to address clinical research organization’s need to more effectively manage and reduce the time it takes to complete the study activation process. Gathered input from multiple NCI-Designated Cancer Centers and documented the results using Use Case models.

Use Case and Application Requirements for a Protocol Lifecycle Tracking Tool, with a Focus on the Trial Initiation Phase – 2010